Markets
CLX

Clorox (CLX) Beats on Q2 Earnings, Raises FY18 EPS View

The Clorox CompanyCLX posted robust second-quarter fiscal 2018 earnings per share which beat estimates, while revenues lagged the same. Notably, earnings marked the fifth straight quarterly beat, while sales missed estimates for after two consecutive beats.

Q2 Highlights

Quarterly earnings from continuing operations of $1.77 per share jumped 55% year over year and surpassed the Zacks Consensus Estimate of $1.22. Results primarily gained from solid sales and lower effective tax rate, offset by fall in gross margin.

Clorox Company (The) Price, Consensus and EPS Surprise

Clorox Company (The) Price, Consensus and EPS Surprise | Clorox Company (The) Quote

Net sales of $1,416 million advanced nearly 0.7% year over year, but lagged the Zacks Consensus Estimate of $1,430 million. The top-line growth was driven by improvement across the International, Lifestyle and Cleaning segments, backed by increased prices. This was partly offset by unfavorable mix.

Clorox witnessed significant pressure on gross margin, which contracted 170 basis points (bps) to 43% in the quarter. Lower margins can be attributed to elevated input costs associated with commodities and further contraction of the transportation market. Additionally, results were hurt by strategic investments in growth and cost savings initiatives, slightly mitigated by benefits of cost savings.

Revenue by Segment

Sales in the Cleaning segment improved 1% to $472 million, mainly driven by strength in Home Care with higher shipments of Clorox disinfecting wipes, along with the launch of Scentiva branded products. This was partly offset by fall in Professional Products business, particularly due to the sale of Aplicare business in August 2017 and unfavorable mix within the segment.

Household sales declined 3% to $410 million due to lower volumes in the Bags & Wraps, Cat Litter and Charcoal businesses, partly negated by double-digit gains in the Digestive Health business due to strength in the e-commerce channel.

Sales at the Lifestyle segment improved 3% to $268 million driven by strength in Water Filtration, which witnessed double-digit volume growth, alongside the launch new Brita Long Last filters and Brita Stream pitchers. Top-line growth also reflected the benefits of improved sales in the Natural Personal Care business.

In the International business segment, sales grew 4% to $266 million on the back of improved pricing. Volumes remained flat as gains in Canada were offset by decline in certain Asian and Latin American countries.

Financials

Clorox ended the quarter with cash and cash equivalents of $489 million, and long-term debt of $1,788 million. In first six months of fiscal 2018, the company generated $322 million of net cash from continuing operations.

Looking Ahead

Following the second-quarter results, the company reiterated sales guidance for fiscal 2018, while it raised the earnings per share view to include the benefits of the new tax reform.

The company continues to expect fiscal 2018 sales growth in a range of 1-3%. The guidance includes nearly 1 percentage point reduction in the fiscal year related to the Aplicare divestiture. It also reflects an estimated 3 percentage point gain from product innovation.

Gross margin is now estimated to decline modestly due to elevated input costs associated with commodities and tightening of the transportation market. This compares with the earlier guidance of being down slightly.

The company now envisions effective tax rate of 23-24% for fiscal 2018 compared with 32-33% guided earlier. In the long term, the company expects effective tax rate in the mid-20s range.

Consequently, the company now anticipates fiscal 2018 earnings from continuing operations to range from $6.17-$6.37 per share, up from the previous guidance of $5.47-$5.67 per share. The company expects fiscal 2018 earnings per share to include 70-75 cents per share gain from the new tax reform, which will be partly offset by lower gross margin.

Clorox currently carries a Zacks Rank #3 (Hold). Shares of Clorox increased 9.5% in the last three months, outperforming the industry 's growth of 1.5%.

Interested in Consumer Staples Space? Check these 3 Hot Picks

Better-ranked stocks in the consumer staples sector include The Boston Beer Co. Inc. SAM , Service Corporation International SCI and Ollie's Bargain Outlet Holdings Inc. OLLI , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Boston Beer, with long-term EPS growth rate of 5%, has increased 10% in the last three months.

Service Corporation has increased 11.9% in the last three months. Moreover, the company has a long-term earnings growth rate of 11.6%.

Ollie's Bargain, with long-term EPS growth rate of 23.5%, has grown 24.2% in last three months.

Breaking News: Cryptocurrencies Now Bigger than Visa

The total market cap of all cryptos recently surpassed $700 billion - more than a 3,800% increase in the previous 12 months. They're now bigger than Morgan Stanley, Goldman Sachs and even Visa! The new asset class may expand even more rapidly in 2018 as new investors continue pouring in and Wall Street becomes increasingly involved.

Zacks has just named 4 companies that enable investors to take advantage of the explosive growth of cryptocurrencies via the stock market.

Click here to access these stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ollie's Bargain Outlet Holdings, Inc. (OLLI): Free Stock Analysis Report

Boston Beer Company, Inc. (The) (SAM): Free Stock Analysis Report

Service Corporation International (SCI): Free Stock Analysis Report

Clorox Company (The) (CLX): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CLX SAM OLLI SCI

Other Topics

Earnings Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More